Alex von Gabain
Foreign Adjunct Professor Alex von Gabain
Alexander von Gabain, PhD, is CSO of Intercell AG, a research-driven biotech company in Vienna, Professor of Microbiology at the Max Perutz Laboratories of the University of Vienna and Foreign Adjunct Professor of Vaccinology at Karolinska Institutet.
After acting as Chairman of the Department of Microbiology and Genetics at the Research Campus of the Vienna Biocenter/ IMP, Alexander founded Intercell, a fast growing biotech company, in 1998. He led the company as CEO for seven years, steering it from a university spin-off to a public listed company (2005; Vienna Stock Exchange: ICLL) with approx. 200 employees worldwide today. In the fall of 2005, Alexander decided to take on new responsibilities as the companys Chief Scientific Officer, committing himself to the companys research and to creating new opportunities from Intercells R&D and technology platforms.
His scientific career has taken Alexander von Gabain to institutions such as the Universities of Heidelberg and Stanford as well as to Karolinska Institutet in Stockholm.
His research interest is in the field of microbial gene expression, host-parasite interactions and immunology. Alexander is a member of several professional organizations, sits on the supervisory board of biotech enterprises, co-edits scientific journals and has organized countless high impact conferences.
He very much looks forward to getting involved with the colleagues and students at KI to exchange and share with them knowledge in his field of research interest, but also in the arena of translating results in biotech enterprises.
Useful links
- Intercell AG, Vienna Biocenter, Austria
- Campus Vienna Biocenter
- GMI (Gregor Mendel Institute of Molecular Plant Biology)
- IMBA (Institute of Molecular Biotechnology)
- IMP (Research Institute of Molecular Pathology)
- Max F. Perutz Laboratories
- Medical University of Vienna
- University of Vienna
Foreign Adjunct Professor Alex von Gabain
- E-mail:
